| Utestående aktier | 5,823,497 shares |
| Insideraktier | 1 471 342 shares |
| Insynsägande | 25,27 % |
| Totalt antal insynspersoner | 46 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
9501 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
NovaBay Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Mark Brian Anderson CSO - [O] | 100 | 3 | |
| Keith R Bley | 258 120 | ||
| Charles Cashion Director - [D] | 18 495 | 584 | |
|
China Pioneer Pharma Holdings Ltd
10% Owner -
|
608 156 | 19 205 | |
| Anthony Dailley Director - [D] | 285 259 | 9 008 | |
| Freiman Paul E. Director - [D] | 1 783 | 51 | |
|
Jian Ping Fu
10% Owner -
|
4 000 000 | 114 286 | |
| Julie Garlikov Director - [D] | 858 | 25 | |
| Justin Hall CEO, GC and Director, Director - [D] [O] | 83 172 | 2 376 | |
| Hoon Russell A. Senior Vice President - [O] | 34 217 | 1 081 | |
| Jones Andrew D. CFO - [O] | 127 461 | 3 642 | |
| Behzad Khosrovi VP, Research & Dev't - [O] | 135 000 | 4 263 | |
| Audrey Kunin Chief Product Officer - [O] | 0 | 0 | |
| Jeffrey Kunin President, DERMAdoctor, LLC - [O] | 0 | 0 | |
| Xiaoyan Liu Director - [D] | 0 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Tommy Law Interim CFO - [O] | 0 | 0 | |
|
Lazar David E.
Chief Executive Officer, Director, 10% Owner -
[D]
[O]
|
0 | 0 | |
|
Xinzhou Li
10% Owner -
|
2 001 743 | 63 213 | |
| Yanbin Liu Director - [D] | 0 | 0 | |
| Yonghao Ma Director - [D] | 0 | 0 | |
| Gail J Maderis | 20 000 | ||
| John Joseph McGovern CFO and Treasurer - [O] | 0 | 0 | |
| McPherson T. Alex Director - [D] | 28 558 | 902 | |
|
Naqu Area Pioneer Pharma Co., Ltd.
10% Owner -
|
800 000 | 25 263 | |
|
Najafi Family Trust dated September 13, 2006
10% Owner -
|
3 117 500 | 98 447 | |
|
Ramin Najafi
Chief Executive Officer, Director, 10% Owner -
[D]
[O]
|
12 000 | 379 | |
| Thomas J Paulson CFO - [O] | 142 196 | 4 490 | |
|
Poplar Point Capital Partners Lp
10% Owner -
|
818 277 | 818 277 | |
|
Pharma (Hong Kong) Co Ltd Pioneer
10% Owner -
|
5 188 421 | 148 241 | |
|
Pioneer Pharma (Singapore) Pte. Ltd.
10% Owner -
|
3 879 519 | 110 843 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Massimo Radaelli | 2 400 | ||
| Jason Philip Raleigh Interim CFO and Treasurer - [O] | 0 | 0 | |
| Mark M Sieczkarek - | 1 156 883 | 33 054 | |
| Lewis J Stuart Chief Commercial Officer - [O] | 0 | 0 | |
| Colin Scott | 72 900 | ||
| Swan Sit Director - [D] | 1 716 | 49 | |
| Stroman David W. SVP, Ophthalmic Product Devt. - [O] | 23 000 | 726 | |
| Tufts Robert R. Director - [D] | 348 408 | 11 002 | |
| Mijia Wu Director - [D] | 1 716 | 49 | |
| Roy J Wu SVP Bus & Corp Development - [O] | 19 296 | 609 | |
| Xiaopei Wang Director - [D] | 0 | 0 | |
| Wicks Tony D.S. Director - [D] | 0 | 0 | |
| Wang Xu NEO - Sr Mgr and Controller - [O] | 42 000 | 1 200 | |
| Todd Erik Zavodnick Director - [D] | 0 | 0 | |
| Yenyou Zheng Director - [D] | 1 716 | 49 | |
| Yongxiang Zheng Director - [D] | 858 | 25 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NBY / NovaBay Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NBY / NovaBay Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-26 | 3 | Lazar David E. | NBY | Common Stock | D | 0 | ||||||||
| 2025-04-15 | 2025-04-08 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,4650 | 300 | 0 | 1 020 300 | ||||
| 2025-04-15 | 2025-04-04 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5216 | 4 538 | 2 | 1 020 000 | ||||
| 2025-04-15 | 2025-04-03 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5627 | 22 976 | 13 | 1 015 462 | ||||
| 2025-04-15 | 2025-04-02 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5800 | 917 | 1 | 992 486 | ||||
| 2025-04-15 | 2025-04-01 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5850 | 19 915 | 12 | 991 569 | ||||
| 2025-04-15 | 2025-03-31 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5900 | 21 654 | 13 | 971 654 | ||||
| 2025-04-15 | 2025-03-28 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6124 | 49 400 | 30 | 950 000 | ||||
| 2025-04-15 | 2025-03-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6090 | 600 | 0 | 900 600 | ||||
| 2025-04-15 | 2025-03-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6150 | 18 504 | 11 | 900 000 | ||||
| 2025-04-15 | 2025-03-26 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6090 | 13 292 | 8 | 881 496 | ||||
| 2025-04-15 | 2025-03-25 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6100 | 22 635 | 14 | 868 204 | ||||
| 2025-04-15 | 2025-03-24 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6050 | 100 | 0 | 845 569 | ||||
| 2025-04-15 | 2025-03-21 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6050 | 6 372 | 4 | 845 469 | ||||
| 2025-04-15 | 2025-03-20 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6149 | 5 320 | 3 | 839 097 | ||||
| 2025-04-15 | 2025-03-19 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6025 | 1 500 | 1 | 833 777 | ||||
| 2025-04-15 | 2025-03-18 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 14 000 | 9 | 832 277 | ||||
| 2025-04-15 | 2025-03-18 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 10 000 | 6 | 818 277 | ||||
| 2025-04-15 | 2025-03-14 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 25 511 | 16 | 808 277 | ||||
| 2025-04-15 | 2025-03-13 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6350 | 34 | 0 | 782 766 | ||||
| 2025-04-15 | 2025-03-12 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6226 | 11 837 | 7 | 782 732 | ||||
| 2025-04-15 | 2025-03-11 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5800 | 2 148 | 1 | 770 895 | ||||
| 2025-04-15 | 2025-03-10 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5800 | 14 645 | 8 | 768 747 | ||||
| 2025-04-15 | 2025-03-07 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5500 | 102 | 0 | 754 102 | ||||
| 2025-04-15 | 2025-03-04 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5784 | 4 000 | 2 | 754 000 | ||||
| 2025-04-15 | 2025-02-28 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6020 | 13 108 | 8 | 750 000 | ||||
| 2025-04-15 | 2025-02-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6100 | 385 | 0 | 736 892 | ||||
| 2025-04-15 | 2025-02-26 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6100 | 6 302 | 4 | 736 507 | ||||
| 2025-04-15 | 2025-02-25 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6199 | 25 033 | 16 | 730 205 | ||||
| 2025-04-15 | 2025-02-24 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6200 | 450 | 0 | 705 172 | ||||
| 2025-04-15 | 2025-02-20 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 1 836 | 1 | 704 722 | ||||
| 2025-04-15 | 2025-02-19 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6715 | 49 664 | 33 | 702 886 | ||||
| 2025-04-15 | 2025-02-18 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6600 | 3 222 | 2 | 653 222 | ||||
| 2025-04-15 | 2025-02-04 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6350 | 26 718 | 17 | 650 000 | ||||
| 2025-04-15 | 2025-02-03 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6350 | 2 597 | 2 | 623 282 | ||||
| 2025-04-15 | 2025-01-31 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6483 | 70 685 | 46 | 620 685 | ||||
| 2025-04-15 | 2025-01-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6900 | 31 703 | 22 | 550 000 | ||||
| 2025-04-07 | 3 | POPLAR POINT CAPITAL PARTNERS LP | NBY | COMMON STOCK, PAR VALUE $0.01 | D | 518 297 | ||||||||
| 2023-05-15 | 2023-05-11 | 4 | Freiman Paul E. | NBY | Common Stock | D | 858 | 1 716 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Zheng Yenyou | NBY | Common Stock | D | 858 | 1 716 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Zheng Yongxiang | NBY | Common Stock | D | 858 | 858 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Sit Swan | NBY | Common Stock | D | 858 | 1 716 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Garlikov Julie | NBY | Common Stock | D | 858 | 858 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | WU MIJIA | NBY | Common Stock | D | 858 | 1 716 | ||||||
| 2023-02-24 | 3 | Law Tommy | NBY | Common Stock | D | 0 | ||||||||
| 2022-12-07 | 2022-12-06 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 1,8100 | −1 | −0 | 0 | ||||
| 2022-12-07 | 2022-12-06 | 4 | Kunin Audrey | NBY | Common Stock | I | 1,8100 | −1 | −0 | 0 | ||||
| 2022-12-05 | 2022-11-21 | 4/A | Kunin Jeffrey | NBY | Common Stock | I | 2,1049 | −5 960 | −13 | 1 | ||||
| 2022-12-05 | 2022-11-21 | 4/A | Kunin Audrey | NBY | Common Stock | I | 2,1049 | −5 960 | −13 | 1 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 2,1049 | −5 960 | −13 | 0 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Kunin Audrey | NBY | Common Stock | I | 2,1049 | −5 960 | −13 | 0 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Hall Justin | NBY | Common Stock | D | 0,1500 | 10 000 | 2 | 83 172 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,1582 | −291 368 | −46 | 208 632 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,1582 | −291 368 | −46 | 208 632 | ||||
| 2022-05-24 | 2022-05-21 | 4 | WU MIJIA | NBY | Restricted Stock Units | D | −30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | WU MIJIA | NBY | Common Stock | D | 30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Zheng Yenyou | NBY | Restricted Stock Units | D | −30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Zheng Yenyou | NBY | Common Stock | D | 30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Freiman Paul E. | NBY | Restricted Stock Units | D | −30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Freiman Paul E. | NBY | Common Stock | D | 30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Sit Swan | NBY | Restricted Stock Units | D | −30 000 | 30 000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Sit Swan | NBY | Common Stock | D | 30 000 | 30 000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Zheng Yenyou | NBY | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Sit Swan | NBY | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Zheng Yongxiang | NBY | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | WU MIJIA | NBY | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Garlikov Julie | NBY | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Freiman Paul E. | NBY | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2022-02-10 | 3 | Zheng Yongxiang | NBY | Common Stock | D | 0 | ||||||||
| 2022-02-03 | 3 | Garlikov Julie | NBY | Common Stock | D | 0 | ||||||||
| 2021-12-07 | 2021-12-03 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4625 | 101 650 | 47 | 500 000 | ||||
| 2021-12-07 | 2021-12-03 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4625 | 101 650 | 47 | 500 000 | ||||
| 2021-12-06 | 2021-12-06 | 4 | Hall Justin | NBY | Common Stock | D | 0,4300 | 69 767 | 30 | 73 172 | ||||
| 2021-12-06 | 2021-12-02 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4760 | 262 369 | 125 | 398 350 | ||||
| 2021-12-06 | 2021-12-06 | 4 | Jones Andrew D. | NBY | Common Stock | D | 0,4400 | 36 765 | 16 | 127 461 | ||||
| 2021-12-06 | 2021-12-03 | 4 | Jones Andrew D. | NBY | Common Stock | D | 0,4400 | 8 690 | 4 | 90 696 | ||||
| 2021-12-06 | 2021-12-02 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4760 | 262 369 | 125 | 398 350 | ||||
| 2021-12-03 | 2021-12-01 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4900 | 14 848 | 7 | 135 981 | ||||
| 2021-12-03 | 2021-12-01 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4900 | 14 848 | 7 | 135 981 | ||||
| 2021-12-02 | 2021-11-30 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4600 | 30 000 | 14 | 121 133 | ||||
| 2021-12-02 | 2021-11-30 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4600 | 30 000 | 14 | 121 133 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4592 | 66 133 | 30 | 91 133 | ||||
| 2021-11-24 | 2021-11-22 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4600 | 25 000 | 12 | 25 000 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4592 | 66 133 | 30 | 91 133 | ||||
| 2021-11-24 | 2021-11-22 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4600 | 25 000 | 12 | 25 000 | ||||
| 2021-11-17 | 3 | Kunin Jeffrey | NBY | Common Stock | D | 0 | ||||||||
| 2021-11-17 | 3 | Kunin Audrey | NBY | Common Stock | D | 0 | ||||||||
| 2021-05-25 | 2021-05-21 | 4 | Zheng Yenyou | NBY | Restricted Stock Unit | D | 30 000 | 30 000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | Li Xinzhou | NBY | Restricted Stock Unit | D | 30 000 | 30 000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | Sit Swan | NBY | Restricted Stock Unit | D | 30 000 | 30 000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | WU MIJIA | NBY | Restricted Stock Unit | D | 30 000 | 30 000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | Freiman Paul E. | NBY | Restricted Stock Unit | D | 30 000 | 30 000 | ||||||
| 2021-05-07 | 2021-05-04 | 4 | Jones Andrew D. | NBY | Common Stock | D | 0,7928 | −77 994 | −62 | 82 006 | ||||
| 2020-08-24 | 2020-08-20 | 4 | Hall Justin | NBY | Stock Option (right to buy) | D | 0,99 | 350 000 | 350 000 | |||||
| 2020-08-24 | 2020-08-20 | 4 | Jones Andrew D. | NBY | Stock Option (right to buy) | D | 0,99 | 25 000 | 25 000 | |||||
| 2020-08-24 | 2020-08-20 | 4 | Xu Wang | NBY | Stock Option (right to buy) | D | 0,99 | 75 000 | 75 000 | |||||
| 2020-08-19 | 2020-08-17 | 4 | WU MIJIA | NBY | Stock Option (right to buy) | D | 0,30 | −20 000 | 0 | |||||
| 2020-08-19 | 2020-08-17 | 4 | WU MIJIA | NBY | Common stock | D | 1,3500 | −20 000 | −27 | 0 | ||||
| 2020-08-19 | 2020-08-17 | 4 | WU MIJIA | NBY | Common stock | D | 0,3000 | 20 000 | 6 | 20 000 | ||||
| 2020-08-04 | 2020-08-01 | 4 | Fu Jian Ping | NBY | Common Stock | D | 1,2300 | −1 302 350 | −1 602 | 4 000 000 | ||||
| 2020-05-29 | 2020-05-26 | 4 | Sit Swan | NBY | Stock option (right to buy) | D | 0,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Freiman Paul E. | NBY | Stock option (right to buy) | D | 0,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Wang Xiaopei | NBY | Stock option (right to buy) | D | 0,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Li Xinzhou | NBY | Stock option (right to buy) | D | 0,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Zheng Yenyou | NBY | Stock option (right to buy) | D | 0,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | WU MIJIA | NBY | Stock option (right to buy) | D | 0,89 | 20 000 | 20 000 | |||||
| 2020-05-13 | 3 | Jones Andrew D. | NBY | Common Stock | D | 320 000 | ||||||||
| 2020-05-13 | 3 | Jones Andrew D. | NBY | Common Stock | D | 320 000 | ||||||||
| 2020-05-13 | 3 | Jones Andrew D. | NBY | Common Stock | D | 320 000 | ||||||||
| 2020-03-19 | 3 | Xu Wang By Spouse | NBY | Common Stock | I | 42 000 | ||||||||
| 2020-03-19 | 3 | Xu Wang By Spouse | NBY | Common Stock | I | 42 000 | ||||||||
| 2020-03-19 | 3 | Xu Wang By Spouse | NBY | Common Stock | I | 42 000 | ||||||||
| 2020-01-28 | 3 | Sit Swan | NBY | Common Stock | D | 0 | ||||||||
| 2019-12-18 | 3 | Wang Xiaopei | NBY | Common Stock | D | 0 | ||||||||
| 2019-10-30 | 2019-05-30 | 4 | Zavodnick Todd Erik | NBY | Stock option (right to buy) | D | 0,30 | 20 000 | 20 000 | |||||
| 2019-10-28 | 2019-06-10 | 4/A | Hall Justin | NBY | Stock Option (right to buy) | D | 2,02 | −47 500 | 0 | |||||
| 2019-10-28 | 2019-06-10 | 4/A | Hall Justin | NBY | Common Stock | D | 3,0300 | −47 500 | −144 | 3 405 | ||||
| 2019-10-28 | 2019-06-10 | 4/A | Hall Justin | NBY | Common Stock | D | 2,0200 | 47 500 | 96 | 50 905 | ||||
| 2019-10-28 | 2019-06-11 | 4/A | Raleigh Jason Philip | NBY | Stock Option (right to buy) | D | 2,35 | −9 750 | 0 | |||||
| 2019-10-28 | 2019-06-11 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 3,7500 | −9 750 | −37 | 0 | ||||
| 2019-10-28 | 2019-06-11 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 2,3500 | 9 750 | 23 | 9 750 | ||||
| 2019-10-28 | 2019-06-10 | 4/A | Raleigh Jason Philip | NBY | Stock Option (right to buy) | D | 2,20 | −23 405 | 0 | |||||
| 2019-10-28 | 2019-06-10 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 3,0000 | −23 405 | −70 | 0 | ||||
| 2019-10-28 | 2019-06-10 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 2,2000 | 23 405 | 51 | 23 405 | ||||
| 2019-10-28 | 2019-05-30 | 4 | Freiman Paul E. | NBY | Stock option (right to buy) | D | 0,30 | 20 000 | 20 000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | SIECZKAREK MARK M | NBY | Stock option (right to buy) | D | 0,30 | 20 000 | 20 000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | Maderis Gail J | NBY | Stock option (right to buy) | D | 0,30 | 20 000 | 20 000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | WU MIJIA | NBY | Stock option (right to buy) | D | 0,30 | 20 000 | 20 000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | Li Xinzhou | NBY | Stock option (right to buy) | D | 0,30 | 20 000 | 20 000 | |||||
| 2019-09-30 | 3 | Zheng Yenyou | NBY | Common Stock | D | 0 | ||||||||
| 2019-08-06 | 2019-07-30 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 167 938 | 1 156 883 | ||||||
| 2019-06-13 | 2019-06-11 | 4 | Fu Jian Ping | NBY | common stock | D | 3,8400 | −380 954 | −1 463 | 5 302 350 | ||||
| 2019-06-13 | 2019-06-11 | 4 | Pioneer Pharma (Hong Kong) Co Ltd | NBY | Common Stock | D | 4,0400 | −24 326 | −98 | 5 188 421 | ||||
| 2019-06-13 | 2019-06-11 | 4 | WU MIJIA Spouse | NBY | Common Stock | I | 4,0400 | −15 873 | −64 | 0 | ||||
| 2019-06-13 | 2019-06-10 | 4 | WU MIJIA | NBY | Common Stock | D | 2,0300 | −47 619 | −97 | 0 | ||||
| 2019-06-12 | 2019-06-11 | 4 | Raleigh Jason Philip | NBY | stock option | D | 2,35 | −9 750 | 0 | |||||
| 2019-06-12 | 2019-06-10 | 4 | Raleigh Jason Philip | NBY | stock option | D | 2,20 | −23 405 | 0 | |||||
| 2019-06-12 | 2019-06-10 | 4 | Hall Justin | NBY | stock option | D | 2,02 | −47 500 | 0 | |||||
| 2019-03-26 | 3 | Raleigh Jason Philip | NBY | Common Stock | D | 0 | ||||||||
| 2018-10-11 | 2018-10-09 | 4 | McGovern John Joseph | NBY | Stock option (right to buy) | D | 1,45 | 250 000 | 440 000 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Zavodnick Todd Erik | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 53 698 | |||||
| 2018-06-04 | 2018-05-31 | 4 | WU MIJIA | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 35 244 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Maderis Gail J | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 84 213 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Ma Yonghao | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 43 629 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Li Xinzhou | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 25 248 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Liu Yanbin | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 20 000 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Freiman Paul E. | NBY | Stock Option (right to buy) | D | 2,20 | 20 000 | 62 697 | |||||
| 2018-06-01 | 2018-05-31 | 4 | Hall Justin | NBY | Stock Option (right to buy) | D | 2,20 | 190 000 | 345 710 | |||||
| 2018-06-01 | 2018-05-31 | 4 | McGovern John Joseph | NBY | Stock Option (right to buy) | D | 2,20 | 90 000 | 190 000 | |||||
| 2018-05-15 | 3 | Liu Yanbin | NBY | Common Stock | D | 0 | ||||||||
| 2018-01-19 | 2017-01-03 | 4/A | Ma Yonghao | NBY | stock option (right to buy) | D | 3,24 | 20 326 | 23 629 | |||||
| 2018-01-08 | 3 | STUART LEWIS J | NBY | Common Stock | D | 0 | ||||||||
| 2018-01-08 | 2017-12-14 | 4 | STUART LEWIS J | NBY | Restricted Stock Unit | D | 3,42 | 10 000 | 10 000 | |||||
| 2018-01-08 | 2017-12-14 | 4 | STUART LEWIS J | NBY | stock option (right to buy) | D | 3,42 | 100 000 | 100 000 | |||||
| 2017-09-18 | 2017-09-14 | 4 | Hall Justin | NBY | stock option | D | 2,78 | −20 000 | 278 160 | |||||
| 2017-08-01 | 3 | McGovern John Joseph | NBY | Common Stock | D | 0 | ||||||||
| 2017-08-01 | 2017-07-17 | 4 | McGovern John Joseph | NBY | Stock option (right to buy) | D | 3,80 | 100 000 | 100 000 | |||||
| 2017-07-07 | 2017-07-03 | 4 | Li Xinzhou | NBY | stock option (right to buy) | D | 3,75 | 5 248 | 5 248 | |||||
| 2017-06-06 | 2017-06-02 | 4 | SIECZKAREK MARK M | NBY | stock option (right to buy) | D | 2,35 | 250 000 | 250 000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | SIECZKAREK MARK M | NBY | stock option (right to buy) | D | 3,60 | 238 609 | 936 857 | |||||
| 2017-01-26 | 2017-01-25 | 4 | PAULSON THOMAS J | NBY | stock option (right to buy) | D | 3,60 | 116 000 | 310 788 | |||||
| 2017-01-26 | 2017-01-25 | 4 | Hall Justin | NBY | stock option (right to buy) | D | 3,60 | 143 000 | 278 160 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Freiman Paul E. | NBY | stock option (right to buy) | D | 3,24 | 25 916 | 67 097 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Freiman Paul E. | NBY | stock option (right to buy) | D | 3,24 | 25 916 | 67 097 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Maderis Gail J | NBY | stock option (right to buy) | D | 3,24 | 23 883 | 59 769 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Zavodnick Todd Erik | NBY | stock option (right to buy) | D | 3,24 | 22 359 | 33 699 | |||||
| 2017-01-04 | 2017-01-03 | 4 | WU MIJIA | NBY | stock option (right to buy) | D | 3,24 | 15 245 | 15 245 | |||||
| 2017-01-04 | 2017-01-03 | 4 | LIU XIAOYAN | NBY | stock option (right to buy) | D | 3,24 | 15 245 | 15 245 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Ma Yonghao | NBY | stock option (right to buy) | D | 3,24 | 33 699 | 37 002 | |||||
| 2016-10-11 | 2016-10-11 | 4 | Fu Jian Ping | NBY | Common Stock | D | 3,1500 | 126 985 | 400 | 3 983 304 | ||||
| 2016-10-04 | 2016-10-03 | 4/A | Zavodnick Todd Erik | NBY | Stock Option (right to buy) | D | 3,99 | 247 | 11 367 | |||||
| 2016-10-04 | 2016-10-03 | 4 | Zavodnick Todd Erik | NBY | Stock Option (right to buy) | D | 3,99 | 3 303 | 14 396 | |||||
| 2016-10-04 | 2016-10-03 | 4 | Ma Yonghao | NBY | Stock Option (right to buy) | D | 3,99 | 3 303 | 3 303 | |||||
| 2016-10-03 | 2016-09-30 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 273 447 | 522 | 988 945 | ||||
| 2016-10-03 | 2016-09-30 | 4 | WU MIJIA | NBY | Common Stock | D | 3,1500 | 15 873 | 50 | 47 619 | ||||
| 2016-09-26 | 2016-09-22 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,8100 | 181 300 | 328 | 3 879 519 | ||||
| 2016-09-26 | 2016-09-22 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 1 308 902 | 2 500 | 5 188 421 | ||||
| 2016-09-26 | 2016-09-22 | 4 | Fu Jian Ping | NBY | Common Stock | D | 1,9100 | 968 587 | 1 850 | 3 856 319 | ||||
| 2016-09-01 | 3 | Ma Yonghao | NBY | NBY | D | 0 | ||||||||
| 2016-08-02 | 2016-08-01 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 1,91 | 130 890 | 273 447 | |||||
| 2016-08-02 | 2016-08-01 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 261 780 | 500 | 715 498 | ||||
| 2016-08-02 | 2016-08-01 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 1,91 | 654 451 | 1 490 202 | |||||
| 2016-08-02 | 2016-08-01 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 1 308 901 | 2 500 | 3 698 219 | ||||
| 2016-07-01 | 2016-07-01 | 4 | Zavodnick Todd Erik | NBY | stock option (right to buy) | D | 2,58 | 11 093 | 0 | |||||
| 2016-06-09 | 2016-06-06 | 4 | Hall Justin | NBY | stock option (right to buy) | D | 2,78 | 130 000 | 135 160 | |||||
| 2016-06-08 | 2016-06-06 | 4 | SIECZKAREK MARK M | NBY | stock option (right to buy) | D | 2,78 | 675 000 | 698 248 | |||||
| 2016-06-08 | 2016-06-06 | 4 | PAULSON THOMAS J | NBY | stock option (right to buy) | D | 2,78 | 160 000 | 194 788 | |||||
| 2016-05-16 | 2016-05-09 | 4 | Fu Jian Ping | NBY | Warrant | D | 1,91 | 968 587 | 1 095 572 | |||||
| 2016-05-16 | 2016-05-09 | 4 | Fu Jian Ping | NBY | Common Stock | D | 1,9100 | 1 937 173 | 3 700 | 2 887 732 | ||||
| 2016-05-13 | 2016-05-09 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 261 780 | 500 | 453 718 | ||||
| 2016-05-13 | 2016-05-09 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 1,91 | 130 890 | 142 557 | |||||
| 2016-05-13 | 2016-05-09 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 1,91 | 654 451 | 835 751 | |||||
| 2016-05-13 | 2016-05-09 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 1 308 901 | 2 500 | 2 389 318 | ||||
| 2016-05-10 | 3 | Zavodnick Todd Erik | NBY | NBY | D | 0 | ||||||||
| 2016-03-09 | 2016-03-09 | 4 | SIECZKAREK MARK M | NBY | Restricted Stock Units | D | 58 692 | 58 692 | ||||||
| 2016-03-09 | 2016-03-09 | 4 | Hall Justin | NBY | Restricted Stock Unit | D | 5 000 | 2 400 | ||||||
| 2016-03-04 | 3 | Fu Jian Ping | NBY | Common Stock | D | 1 901 118 | ||||||||
| 2016-03-04 | 3 | Fu Jian Ping | NBY | Common Stock | D | 1 901 118 | ||||||||
| 2016-02-26 | 2016-02-25 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 125 387 | 239 | 133 246 | ||||
| 2016-02-26 | 2016-02-25 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 696 590 | 1 330 | 1 104 742 | ||||
| 2016-02-01 | 3 | LIU XIAOYAN | NBY | No securities are beneficially owned. | D | 0 | ||||||||
| 2016-02-01 | 3 | WU MIJIA | NBY | Common Stock | D | 63 492 | ||||||||
| 2016-02-01 | 3 | WU MIJIA | NBY | Common Stock | D | 63 492 | ||||||||
| 2016-01-08 | 3 | Hall Justin | NBY | Common Stock | D | 800 | ||||||||
| 2016-01-08 | 3 | Hall Justin | NBY | Common Stock | D | 800 | ||||||||
| 2016-01-06 | 2016-01-04 | 4 | Radaelli Massimo | NBY | Common Stock (right to buy) | D | 2,02 | 600 | 2 400 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Maderis Gail J | NBY | Stock Option (right to buy) | D | 2,02 | 24 777 | 35 886 | |||||
| 2016-01-06 | 2016-01-04 | 4 | McPherson T. Alex | NBY | Common Stock (right to buy) | D | 2,02 | 22 719 | 44 210 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Freiman Paul E. | NBY | Stock Option (right to buy) | D | 2,02 | 26 835 | 41 181 | |||||
| 2016-01-06 | 2016-01-04 | 4 | SIECZKAREK MARK M | NBY | Stock Option (right to buy) | D | 2,02 | 16 032 | 23 246 | |||||
| 2015-10-06 | 2015-10-05 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 0,27 | 100 000 | 474 834 | |||||
| 2015-10-06 | 2015-10-05 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 0,27 | 150 000 | 869 675 | |||||
| 2015-10-06 | 2015-10-05 | 4 | PAULSON THOMAS J | NBY | Restricted Stock Unit | D | 50 000 | 142 196 | ||||||
| 2015-10-06 | 2015-10-05 | 4 | WU ROY J | NBY | Restricted Stock Unit | D | 0,00 | 25 000 | 25 000 | |||||
| 2015-10-06 | 2015-10-05 | 4 | WU ROY J | NBY | Option (right to buy) | D | 0,27 | 150 000 | 614 725 | |||||
| 2015-08-21 | 2015-08-20 | 4 | Najafi Ramin Individual Retirement Account | NBY | Common Stock | I | 0,4400 | 6 000 | 3 | 12 000 | ||||
| 2015-08-21 | 2015-08-19 | 4 | Najafi Ramin Individual Retirement Account | NBY | Common Stock | I | 0,5000 | 6 000 | 3 | 6 000 | ||||
| 2015-06-16 | 2015-06-12 | 4 | SIECZKAREK MARK M | NBY | Stock Option (right to buy) | D | 0,79 | 24 128 | 180 362 | |||||
| 2015-04-30 | 2015-04-14 | 4/A | Hoon Russell A. | NBY | Common Stock | D | 4 515 | 34 217 | ||||||
| 2015-04-15 | 2015-04-14 | 4 | Hoon Russell A. | NBY | Restricted Stock Unit | D | 4 515 | 34 217 | ||||||
| 2015-03-25 | 2015-03-23 | 4 | PAULSON THOMAS J | NBY | Restricted Stock Unit | D | 23 986 | 92 196 | ||||||
| 2015-03-25 | 2015-03-23 | 4 | WU ROY J | NBY | Restricted Stock Unit | D | 19 296 | 19 296 | ||||||
| 2015-03-25 | 2015-03-23 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Restricted Stock Unit | I | 46 033 | 3 437 699 | ||||||
| 2015-03-05 | 2015-03-03 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 0,65 | 0,6500 | 124 999 | 81 | 291 665 | |||
| 2015-03-05 | 2015-03-03 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 0,60 | 0,6000 | 166 666 | 100 | 291 665 | |||
| 2015-03-05 | 2015-03-03 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 0,6000 | 166 666 | 100 | 196 466 | ||||
| 2015-03-05 | 2015-03-03 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 0,65 | 0,6500 | 1 942 500 | 1 263 | 4 532 500 | |||
| 2015-03-05 | 2015-03-03 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 0,60 | 0,6000 | 2 590 000 | 1 554 | 4 532 500 | |||
| 2015-03-05 | 2015-03-03 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 0,6000 | 2 590 000 | 1 554 | 9 595 656 | ||||
| 2015-03-05 | 2015-03-03 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Warrant | I | 0,65 | 0,6500 | 124 999 | 81 | 291 665 | |||
| 2015-03-05 | 2015-03-03 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Warrant | I | 0,60 | 0,6000 | 166 666 | 100 | 291 665 | |||
| 2015-03-05 | 2015-03-03 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Common Stock | I | 0,6000 | 166 666 | 100 | 3 391 666 | ||||
| 2015-01-06 | 2015-01-02 | 4 | Cashion Charles | NBY | Stock Option (right to buy) | D | 0,64 | 69 368 | 377 156 | |||||
| 2015-01-06 | 2015-01-02 | 4 | McPherson T. Alex | NBY | Stock Option (right to buy) | D | 0,64 | 144 444 | 537 279 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Radaelli Massimo | NBY | Stock Option (right to buy) | D | 0,64 | 15 000 | 45 000 | |||||
| 2015-01-06 | 2015-01-02 | 4 | SIECZKAREK MARK M | NBY | Stock Option (right to buy) | D | 0,64 | 92 667 | 156 234 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Maderis Gail J | NBY | Stock Option (right to buy) | D | 0,64 | 121 144 | 277 726 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Freiman Paul E. | NBY | Stock Option (right to buy) | D | 0,64 | 121 144 | 358 654 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Wicks Tony D.S. | NBY | Stock Option (right to buy) | D | 0,64 | 15 000 | 301 016 | |||||
| 2014-12-24 | 3 | Hoon Russell A. | NBY | Restricted Stock Unit | D | 59 404 | ||||||||
| 2014-12-24 | 3 | Hoon Russell A. | NBY | Restricted Stock Unit | D | 59 404 | ||||||||
| 2014-12-16 | 2014-12-12 | 4 | Stroman David W. | NBY | Common Stock | D | 0,6600 | 10 000 | 7 | 23 000 | ||||
| 2014-12-15 | 2014-12-12 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,6500 | 50 000 | 32 | 0 | ||||
| 2014-12-15 | 2014-12-12 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 0,6800 | 10 000 | 7 | 68 210 | ||||
| 2014-12-11 | 2014-12-09 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 0,6700 | 10 000 | 7 | 58 210 | ||||
| 2014-12-11 | 2014-12-11 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,6000 | 20 000 | 12 | 3 175 000 | ||||
| 2014-12-08 | 2014-12-05 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,6500 | 25 000 | 16 | 3 155 000 | ||||
| 2014-12-04 | 2014-12-02 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,7100 | 18 000 | 13 | 3 130 000 | ||||
| 2014-12-04 | 2014-12-02 | 4 | Wicks Tony D.S. | NBY | Common Stock | D | 0,7000 | −20 000 | −14 | 0 | ||||
| 2014-12-03 | 2014-12-01 | 4 | Wicks Tony D.S. | NBY | Common Stock | D | 0,6900 | −10 000 | −7 | 213 680 | ||||
| 2014-09-30 | 2014-09-26 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 0,75 | 50 000 | 374 834 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 0,75 | 90 000 | 1 015 032 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Bley Keith R | NBY | Option (right to buy) | D | 0,75 | 50 000 | 258 120 | |||||
| 2014-09-30 | 2014-09-26 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 0,75 | 60 000 | 719 675 | |||||
| 2014-09-30 | 2014-09-26 | 4 | WU ROY J | NBY | Option (right to buy) | D | 0,75 | 50 000 | 464 725 | |||||
| 2014-06-05 | 2014-06-04 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 0,8900 | 4 800 | 4 | 29 800 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Najafi Ramin Najafi Family Trust | NBY | Common Stock | I | −5 500 | 3 112 000 | ||||||
| 2014-05-21 | 2014-05-19 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 0,8800 | 25 000 | 22 | 25 000 | ||||
| 2014-05-14 | 2014-05-09 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 0,9900 | 318 828 | 316 | 426 984 | ||||
| 2014-05-14 | 2014-05-12 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 0,9900 | 116 107 | 115 | 543 091 | ||||
| 2014-05-14 | 2014-05-13 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 0,9900 | 65 065 | 64 | 608 156 | ||||
| 2014-04-17 | 2014-04-15 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,00 | 7 823 | 414 725 | |||||
| 2014-04-17 | 2014-04-15 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,00 | 9 866 | 699 675 | |||||
| 2014-04-17 | 2014-04-15 | 4 | Bley Keith R | NBY | Option (right to buy) | D | 1,00 | 7 120 | 208 120 | |||||
| 2014-04-17 | 2014-04-15 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,00 | 10 180 | 925 032 | |||||
| 2014-04-17 | 2014-04-15 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,00 | 5 011 | 324 834 | |||||
| 2014-04-14 | 2014-04-14 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 0,56 | −52 000 | 234 068 | |||||
| 2014-04-14 | 2014-04-14 | 4 | Wicks Tony D.S. | NBY | Common Stock | D | 0,5600 | 52 000 | 29 | 213 690 | ||||
| 2014-03-21 | 2014-03-17 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 0,56 | −9 000 | 191 967 | |||||
| 2014-03-21 | 2014-03-17 | 4 | Dailley Anthony | NBY | Common Stock | D | 0,5600 | 9 000 | 5 | 285 259 | ||||
| 2014-01-31 | 2014-01-30 | 4 | SIECZKAREK MARK M | NBY | Option (right to buy) | D | 1,14 | 33 567 | 63 567 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,14 | 14 919 | 286 068 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,14 | 30 583 | 191 468 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,14 | 31 329 | 307 788 | |||||
| 2014-01-31 | 2014-01-30 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,14 | 86 528 | 382 335 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,14 | 61 167 | 267 631 | |||||
| 2014-01-09 | 2014-01-09 | 4 | SIECZKAREK MARK M | NBY | Option (right to buy) | D | 1,25 | 30 000 | 30 000 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,29 | 15 000 | 271 149 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 1,29 | 15 000 | 237 510 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,29 | 15 000 | 160 885 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,29 | 15 000 | 203 217 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,29 | 15 000 | 276 459 | |||||
| 2014-01-09 | 2014-01-02 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,29 | 15 000 | 295 807 | |||||
| 2014-01-09 | 2014-01-09 | 4 | Radaelli Massimo | NBY | Option (right to buy) | D | 1,25 | 30 000 | 30 000 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,29 | 15 000 | 206 464 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | D | 1,50 | −1 200 000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | D | 1,50 | −800 000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,1400 | 5 000 000 | 5 700 | 7 005 656 | ||||
| 2013-12-04 | 2013-12-02 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | −1 200 000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | −800 000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 1,1400 | 5 000 000 | 5 700 | 7 005 656 | ||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | −1 200 000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | −800 000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 1,1400 | 5 000 000 | 5 700 | 7 005 656 | ||||
| 2013-12-02 | 2013-07-22 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 3 913 | 2 005 656 | ||||||
| 2013-12-02 | 2013-04-29 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1 743 | 2 001 743 | ||||||
| 2013-12-02 | 2013-04-29 | 4 | Li Xinzhou By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 1 743 | 2 001 743 | ||||||
| 2013-12-02 | 2013-09-20 | 4 | Li Xinzhou | NBY | Common Stock | D | 1,8749 | −120 000 | −225 | 0 | ||||
| 2013-12-02 | 3 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 2 001 743 | ||||||||
| 2013-12-02 | 2013-11-14 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 1,0200 | 108 156 | 110 | 108 156 | ||||
| 2013-12-02 | 2013-07-22 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 3 913 | 2 005 656 | ||||||
| 2013-12-02 | 3 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 2 001 743 | ||||||||
| 2013-12-02 | 2013-07-22 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 3 913 | 2 005 656 | ||||||
| 2013-10-29 | 2013-10-28 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 1,7500 | −3 645 | −6 | 63 855 | ||||
| 2013-10-29 | 2013-10-28 | 4 | Najafi Ramin | NBY | Common Stock | D | 1,7500 | −4 557 | −8 | 100 195 | ||||
| 2013-10-02 | 2013-09-26 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,71 | −110 000 | 689 809 | |||||
| 2013-10-02 | 2013-09-26 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,71 | 62 000 | 406 902 | |||||
| 2013-10-02 | 2013-09-26 | 4 | Bley Keith R | NBY | Option (right to buy) | D | 1,71 | 51 000 | 201 000 | |||||
| 2013-10-02 | 2013-09-26 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,71 | −150 000 | 914 852 | |||||
| 2013-10-02 | 2013-09-26 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,71 | −62 000 | 319 823 | |||||
| 2013-03-06 | 2013-03-05 | 4 | Bley Keith R | NBY | Options (right to buy) | D | 1,15 | 150 000 | 150 000 | |||||
| 2013-02-01 | 2013-01-30 | 4 | Wicks Tony D.S. | NBY | Options (right to buy) | D | 1,29 | 19 603 | 256 149 | |||||
| 2013-02-01 | 2013-01-30 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,29 | 19 603 | 261 459 | |||||
| 2013-02-01 | 2013-01-30 | 4 | McPherson T. Alex | NBY | option (right to buy) | D | 1,29 | 39 205 | 280 807 | |||||
| 2013-02-01 | 2013-01-30 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,29 | 39 205 | 191 464 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,13 | 15 000 | 236 546 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 1,13 | 15 000 | 222 510 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,13 | 15 000 | 145 885 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,13 | 15 000 | 188 217 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,13 | 15 000 | 241 856 | |||||
| 2013-01-15 | 2013-01-02 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,13 | 15 000 | 241 602 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,13 | 15 000 | 152 259 | |||||
| 2013-01-14 | 2013-01-10 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,13 | 25 000 | 579 809 | |||||
| 2013-01-14 | 2013-01-10 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,13 | 25 000 | 344 902 | |||||
| 2013-01-14 | 2013-01-10 | 4 | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,13 | 25 000 | 536 283 | |||||
| 2013-01-14 | 2013-01-10 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,13 | 85 000 | 764 852 | |||||
| 2013-01-14 | 2013-01-20 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,13 | 25 000 | 257 823 | |||||
| 2013-01-03 | 2012-12-11 | 4 | Li Xinzhou | NBY | Common Stock | D | 1,2000 | 120 000 | 144 | 2 120 000 | ||||
| 2013-01-02 | 2012-09-13 | 4 | Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq | NBY | Warrant | I | 1,50 | 1,5000 | 800 000 | 1 200 | 800 000 | |||
| 2013-01-02 | 2012-09-13 | 4 | Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | NBY | Common Stock | I | 1,2500 | 800 000 | 1 000 | 800 000 | ||||
| 2013-01-02 | 3 | Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | NBY | Common Stock | I | 800 000 | ||||||||
| 2013-01-02 | 2012-10-31 | 4 | Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq | NBY | Warrant | I | 1,50 | 1,5000 | 1 200 000 | 1 800 | 2 000 000 | |||
| 2013-01-02 | 2012-10-31 | 4 | Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | NBY | Common Stock | I | 1,2500 | 1 200 000 | 1 500 | 2 000 000 | ||||
| 2012-12-10 | 2012-12-06 | 4 | PAULSON THOMAS J | NBY | warrant to purchase Common Stock | D | 1,50 | 0,0100 | 7 500 | 0 | 7 500 | |||
| 2012-12-10 | 2012-12-06 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 1,2400 | 10 000 | 12 | 63 855 | ||||
| 2012-12-10 | 2012-12-06 | 4 | Najafi Ramin | NBY | Warrants to Purchase Common Shares | D | 1,50 | 0,0100 | 15 000 | 0 | 15 000 | |||
| 2012-12-10 | 2012-12-06 | 4 | Najafi Ramin | NBY | Common Stock | D | 1,2400 | 20 000 | 25 | 100 195 | ||||
| 2012-12-10 | 2012-12-06 | 4 | Stroman David W. | NBY | Warrants to purchase Common Stock | D | 1,50 | 0,0100 | 7 500 | 0 | 7 500 | |||
| 2012-12-10 | 2012-12-06 | 4 | Stroman David W. | NBY | Common Stock | D | 1,2400 | 10 000 | 12 | 22 000 | ||||
| 2012-12-04 | 2012-10-27 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 1,3100 | −3 645 | −5 | 53 855 | ||||
| 2012-12-04 | 2012-10-27 | 4 | Najafi Ramin | NBY | Common Stock | D | 1,3100 | −4 557 | −6 | 80 195 | ||||
| 2012-11-20 | 2012-10-31 | 4 | NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma Co. | NBY | Warrant | I | 1,50 | 1,5000 | 1 200 000 | 1 800 | 2 000 000 | |||
| 2012-11-20 | 2012-10-31 | 4 | NAQU AREA PIONEER PHARMA CO., LTD. Shares are held directly by Pioneer Pharma (Singapore) Pte. Ltd. Pioneer Pharma (Singapore) Pte. Lt | NBY | Common Stock | I | 1,2500 | 1 200 000 | 1 500 | 2 000 000 | ||||
| 2012-11-20 | 3 | NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. is a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma C | NBY | Common Stock | I | 800 000 | ||||||||
| 2012-11-05 | 2012-10-31 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 1,50 | 1,5000 | 1 200 000 | 1 800 | 2 000 000 | |||
| 2012-11-05 | 2012-10-31 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,2500 | 1 200 000 | 1 500 | 2 000 000 | ||||
| 2012-11-05 | 3 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 800 000 | ||||||||
| 2012-11-01 | 2012-09-26 | 4/A | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,22 | 25 000 | 554 809 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | Stroman David W. | NBY | Option (right to buy) | D | 1,22 | 25 000 | 232 823 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | WU ROY J | NBY | Option (right to buy) | D | 1,22 | 25 000 | 319 902 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,22 | 25 000 | 511 283 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | Najafi Ramin | NBY | Option (right to buy) | D | 1,22 | 65 000 | 679 852 | |||||
| 2012-11-01 | 2012-09-27 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 0,56 | 0,5600 | −28 500 | −16 | 0 | |||
| 2012-11-01 | 2012-09-27 | 4 | Tufts Robert R. ROBERT R TUFTS & JOYCE A TUFTS TR ROBERT & JOYCE TUFTS TRUST UA 09/18/87 | NBY | Common Stock | I | 0,5600 | 28 500 | 16 | 348 408 | ||||
| 2012-10-12 | 2012-10-10 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,29 | 25 000 | 554 809 | |||||
| 2012-10-12 | 2012-10-10 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,29 | 25 000 | 319 902 | |||||
| 2012-10-12 | 2012-10-10 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,29 | 65 000 | 679 852 | |||||
| 2012-10-12 | 2012-10-10 | 4 | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,29 | 25 000 | 511 283 | |||||
| 2012-10-12 | 2012-10-10 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,29 | 25 000 | 232 823 | |||||
| 2012-05-31 | 2012-05-30 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 0,9364 | 10 000 | 9 | 17 500 | ||||
| 2012-05-30 | 2012-05-29 | 4 | Najafi Ramin | NBY | Common | D | 0,9600 | 2 000 | 2 | 34 752 | ||||
| 2012-05-30 | 2012-05-29 | 4 | Najafi Ramin | NBY | Common | D | 0,9590 | 4 000 | 4 | 32 752 | ||||
| 2012-05-29 | 2012-05-25 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,9900 | 3 500 | 3 | 28 752 | ||||
| 2012-04-02 | 2007-10-25 | 5/A | Stroman David W. | NBY | Common Stock | D | 4,0000 | 2 000 | 8 | 2 000 | ||||
| 2012-02-23 | 2012-02-17 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,44 | 54 709 | 529 809 | |||||
| 2012-02-23 | 2012-02-17 | 4 | WU ROY J | NBY | Option (Right to Buy) | D | 1,44 | 48 902 | 294 902 | |||||
| 2012-02-23 | 2012-02-17 | 4 | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,44 | 52 083 | 486 283 | |||||
| 2012-02-23 | 2012-02-17 | 4 | Najafi Ramin | NBY | Option (right to purchase) | D | 1,44 | 96 652 | 614 852 | |||||
| 2012-02-23 | 2012-02-17 | 4 | Stroman David W. | NBY | Option (Right to Buy) | D | 1,44 | 7 823 | 207 823 | |||||
| 2012-02-13 | 2011-06-16 | 5 | Stroman David W. | NBY | Common Stock | D | 1,0100 | 10 000 | 10 | 10 000 | ||||
| 2012-01-05 | 2012-01-03 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,33 | 66 230 | 66 230 | |||||
| 2012-01-05 | 2011-12-29 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 0,20 | 0,2000 | −30 000 | −6 | 30 000 | |||
| 2012-01-05 | 2011-12-29 | 4 | Freiman Paul E. PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TTEES PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TR U/A DTD 5 | NBY | Common Stock | I | 0,2000 | 30 000 | 6 | 45 137 | ||||
| 2012-01-05 | 2012-01-03 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,33 | 67 510 | 67 510 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Freiman Paul E. | NBY | Option(right to buy) | D | 1,33 | 67 510 | 67 510 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,33 | 66 230 | 66 230 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,33 | 68 791 | 68 791 | |||||
| 2012-01-05 | 2012-01-03 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,33 | 79 037 | 79 037 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,33 | 67 510 | 67 510 | |||||
| 2011-02-01 | 2008-09-05 | 4/A | Scott Colin | NBY | Option (right to buy) | D | 1,95 | 35 400 | 72 900 | |||||
| 2011-02-01 | 2008-09-05 | 4/A | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,95 | 44 400 | 244 400 | |||||
| 2011-02-01 | 2008-09-05 | 4/A | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,95 | 35 400 | 72 900 | |||||
| 2011-01-27 | 2009-01-14 | 4/A | McPherson T. Alex | NBY | Common Stock | D | 9 084 | 28 558 | ||||||
| 2011-01-27 | 2009-01-14 | 4/A | Cashion Charles By the Charles J. Cashion and Martha Diane Cashion Trust u/d/t dated July 27, 1998 | NBY | Common Stock | I | 8 239 | 18 495 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 1 353 | 204 056 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Dailley Anthony By the Anthony & Terry Dailley Trust, u/a/d 1991 | NBY | Common Stock | I | 1 353 | 146 047 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust dated 5/24/95 | NBY | Common Stock | I | 1 353 | 33 412 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 1 353 | 140 657 | ||||||
| 2011-01-05 | 2011-01-03 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,67 | 15 000 | 15 000 | |||||
| 2011-01-05 | 2011-01-03 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 1,67 | 15 000 | 15 000 | |||||
| 2011-01-05 | 2011-01-03 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,67 | 27 375 | 27 375 | |||||
| 2011-01-05 | 2011-01-03 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,67 | 15 000 | 15 000 | |||||
| 2009-10-15 | 3 | Anderson Mark Brian | NBY | Common Stock | D | 100 | ||||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Series C Preferred Stock | I | 0,00 | −17 647 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Series B Preferred Stock | I | 0,00 | −32 000 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | NBY | Series B Preferred Stock | I | 0,00 | −10 638 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Series A Preferred Stock | I | 0,00 | −57 143 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | −8 823 | 138 423 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | 16 000 | 129 600 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | NBY | Common Stock | I | 5 319 | 7 180 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | 28 572 | 113 600 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Khosrovi Behzad | NBY | Series B Preferred Stock | D | 0,00 | −200 000 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Khosrovi Behzad | NBY | Common Stock | D | 100 000 | 135 000 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | McPherson T. Alex | NBY | Series D Preferred Stock | D | 0,00 | −16 666 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | McPherson T. Alex | NBY | Common Stock | D | 8 333 | 8 333 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Series A Preferred Stock | I | 0,00 | −142 857 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 4,0000 | 67 500 | 270 | 194 499 | ||||
| 2007-10-31 | 2007-10-31 | 4 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 71 428 | 126 999 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Series B Preferred Stock | I | 0,00 | −30 000 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Series A Preferred Stock | I | 0,00 | −71 429 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 15 000 | 130 964 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 35 714 | 115 964 | ||||||
| 2007-10-24 | 3 | Najafi Family Trust dated September 13, 2006 By the Najafi Family Trust dated September 13, 2006 | NBY | Common Stock | I | 3 117 500 | ||||||||
| 2007-10-24 | 3 | Khosrovi Behzad | NBY | Common Stock | D | 35 000 | ||||||||
| 2007-10-24 | 3 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | 85 028 | ||||||||
| 2007-10-24 | 3 | Dailley Anthony | NBY | Common Stock | D | 75 000 | ||||||||
| 2007-10-24 | 3 | Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | NBY | Common Stock | I | 1 861 | ||||||||
| 2007-10-24 | 3 | Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust | NBY | Common Stock | I | 25 000 | ||||||||
| 2007-10-24 | 3 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 55 571 | ||||||||
| 2007-10-24 | 3 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 80 250 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
